Drawing for BEYOND THE EDGE AND THE SKIN

USPTO serial 79325647

BEYOND THE EDGE AND THE SKIN

Reviewed by CopyMark Law Group

Reg. 7141151Status 700Registered
Filing date
Status date
Registration date
Aug 22, 2023
Examiner
LAM, HAI-LY HUYNH
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BEYOND THE EDGE AND THE SKIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

ANDY I. COREA

Andy I. Corea Murtha Cullina LLP265 Church StreetNew Haven, CT 06510-1220UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003Cosmetics; cosmetic patches, namely, non-medicated cosmetic patches containing anti-aging ingredients for skin care and cosmetic patches containing non-medicated skin care preparations; sheet shaped facial cosmetics, namely, facial sheet masks for cosmetic use; beauty masks; facial beauty masks; skin cleansing foams; beauty serums; creamy beauty serumsACTIVE—
005Cosmetics for medical use, namely, medicated cosmetics; dietary supplement patches; adhesive medical plasters containing dietary supplements; transdermal patches featuring dietary supplements; adhesive sheet for medical use, namely, adhesive bandages; hair growth agent, namely, hair growth stimulants, medicinal hair growth preparationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 6, 2026ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Dec 11, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 22, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 22, 2023FIMPFINAL DISPOSITION PROCESSED—
Nov 22, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 22, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 22, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 6, 2023GPNXNOTIFICATION PROCESSED BY IB—
Jun 6, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 6, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 17, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 17, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
May 17, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 9, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 28, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 28, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 28, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 27, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Apr 27, 2023EXPIEX PARTE APPEAL-INSTITUTED—
Apr 27, 2023JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Apr 27, 2023EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Apr 19, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 19, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Oct 28, 2022GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Oct 28, 2022GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 28, 2022CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 30, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 30, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 30, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 4, 2022RFNTREFUSAL PROCESSED BY IB—
Apr 11, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 11, 2022RFRRREFUSAL PROCESSED BY MPU—
Mar 9, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 8, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2022DOCKASSIGNED TO EXAMINER—
Nov 30, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 26, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 23, 2021LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Nov 18, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance